Orchid Pharma Limited — Others, 28-02-2025: Action(s) taken or orders passed

Orchid Pharma has announced a board meeting to address an order received from the Goods and Services Tax Department related to the financial year 2020-2021. The order, amounting to approximately ₹1.44 crore, includes a tax liability of ₹0.80 crore, interest of ₹0.56 crore, and a penalty of ₹0.08 crore. The company asserts that the order is unjustified and plans to appeal against it. Management believes this order will not materially affect its financial health or operations. This situation may create a neutral impact for investors, with potential risks mitigated by the company's planned legal recourse.